Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Sequential Mitomycin and Bacillus Calmette-Guérin Treatment Versus Bacillus Calmette-Guérin Monotherapy in Patients With High Risk Non-Muscle Invasive Bladder Cancer

NCT03790384 is registered in ClinicalTrials.gov with Azienda Ospedaliera "Sant'Andrea" as lead sponsor.

NCT NCT03790384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03790384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Sequential Mitomycin and Bacillus Calmette-Guérin Treatment Versus Bacillus Calmette-Guérin Monotherapy in Patients With High Risk Non-Muscle Invasive Bladder Cancer
Lead sponsor
Azienda Ospedaliera "Sant'Andrea"
Phase
Phase 4
Overall status
Unknown status
Start date
January 15, 2019
Completion date
January 15, 2021
Enrollment
140 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer